Point-of-Care Molecular Diagnostics Market 2021 Highest Boost in Business Growth, Demand and Size-share | Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, BioMerieux, Bio-Rad Laboratories.

The Point-of-Care Molecular Diagnostics market is expected to register a CAGR of 14% over the forecast period.

Point-of-Care (POC) Molecular testing enables physicians to improve the standard of care by combining quick diagnosis with treatment decision in the first visit by the patient instead of hours and days to have the test results. This would help prescribe treatment in the first instance without having to wait for final results. In past decades, the prevalence of infectious diseases and chronic illnesses like cancer have increased. This has led to an increase in demand for novel diagnostic methods, which has led to progress in technological advancements and pharmacogenomics. This has also increased the demand for POC testing. These factors have helped the growth of the POC molecular testing market.

Molecular diagnostics has been conducted in the centralized laboratories since many years; however, its few drawbacks like delay in results, high cost of tests, less accuracy, and late disease diagnosis are leading to increase in mortality rate, thereby hindering the growth of this market. Thus, to overcome this, the new field named as point of care molecular diagnostics has emerged.

The report is updated with the impact of the currently ongoing COVID-19 pandemic. The pandemic has dynamically affected key market segments and changed the growth pattern and demands in the Point-of-Care Molecular Diagnostics market. The report covers an in-depth analysis of these changes and provides an accurate estimate of the market growth forecast after the impact of the pandemic.

Request for a sample report here @  https://www.reportconsultant.com/request_sample.php?id=90823     

Some of the key players operating in the Point-of-Care Molecular Diagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, BioMerieux, Bio-Rad Laboratories

Market Definition

Point-of-Care (POC) Molecular diagnostics are the tests that are performed at a site near to the patient. It can be done in a hospital, clinic, ambulance, field, or physician’s office. POC molecular diagnostics is fast and efficient and therefore reaches more patients. The test results are fast and thus ensures that timely treatment is offered to the patients. It also eliminates the follow-up visits of the patient. Molecular technologies are employed that tests the nucleic acid or the DNA of the patient for the detection of any pathogens, infections, tumors or abnormalities. These are the tests that are used to detect specific sequences in DNA or RNA that may or may not be associated with disease, including single nucleotide polymorphism (SNP), insertions, rearrangements, deletions and others. The clinical applications of molecular diagnostics can be found in at least six wide-ranging areas that are oncology, pharmacogenomics, human leukocyte antigen typing, infectious diseases, genetic disease screening and coagulation.

Three basic steps are required for each molecular analysis, The first step is extraction and purification of nucleic acid, followed by the second step that is amplification or making copies of the nucleic acid of interest (target) or attaching multiple copies of a dye to a single target copy, and third and the last step is the detection of the amplified target using real time polymerase chain reaction (PCR) or end product detection including microarrays, Luminex i.e. similar to flow cytometry or sequencing. All three steps can be performed together or separately according to the convenience of the doctors and physicians.

Market Overview

Growing demand for CLIA tests that are, by definition, portable and safe enough to be used in non-laboratory settings such as pharmacy clinics, physician offices, and home-care settings, is expected to drive demand in the market over the forecast period. Ongoing research and development is continually supported and funded by a number of major international entities including the governments of developed countries.

Market segmentation:
This report segments the market on the basis of by type are:

Assays & Kits
Instruments/Analyzers
Software & Services

On the basis by application, the market is segmented into:

Infectious Diseases
Oncology, Hematology
Prenatal Testing
Endocrinology
Other Applications

Key Market Trends

Application in Oncology is Expected to Register a High CAGR

Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 17 million new cancer cases worldwide in 2018.

Many current point-of-care (POC) diagnostics utilize lateral flow immunoassay-based technologies. Lateral flow immunoassays are devices that incorporate antibodies to detect the presence of an analyte like cancer biomarkers. In principle, a lateral flow test is a device that will provide a qualitative answer to the presence of a biomarker in a short period of time. Hence, the demand for these quick detection tests is expected to increase as the incidence of cancer increases.

The report is mainly segmented into several key regions, with sales, revenue, market share, and growth rate in these regions, covering:

North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Enquiry Before Buying: https://www.reportconsultant.com/enquiry_before_buying.php?id=90823

Table of Contents: -

1. Global Point-of-Care Molecular Diagnostics Market Overview
2. Global Point-of-Care Molecular Diagnostics Market Competitions by Manufacturers
3. Global Point-of-Care Molecular Diagnostics Capacities, Production, Revenue (Value) by Region
4. Global Point-of-Care Molecular Diagnostics Supply (Production), Consumption, Export, Import by Region
5. Global Point-of-Care Molecular Diagnostics Productions, Revenue (Value), Price Trend by Type
6. Global Point-of-Care Molecular Diagnostics Market Analyses by Application
7. Global Point-of-Care Molecular Diagnostics Manufacturers Profiles/Analysis
8. Point-of-Care Molecular Diagnostics Manufacturing Cost Analysis
9. Industrial Chain, Sourcing Strategy and Downstream Buyers
10. Marketing Strategy Analyses, Distributors/Traders
11. Market Effect Factors Analysis
12. Global Point-of-Care Molecular Diagnostics Market Forecast
13. Research Findings and Conclusion
14. Appendixes

The research includes historic data from 2015 to 2021 and forecasts until 2028 which makes the report's an invaluable resource for industry executives, Marketing, Sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Note- At Report Consultant, our main forte is to custom make research reports as per your requirements. Do share your niche requirements, if any.

Contact us:
Riaana Singh
(Report Consultant)
sales@reportconsultant.com | www.reportconsultant.com

About Us:

Report Consultant – A worldwide pacesetter in analytics, research and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly by taking calculative risks leading to lucrative business in the ever-changing market. We make sense of drawbacks, opportunities, circumstances, estimations and information using our experienced skills and verified methodologies.

Our research reports will give you the most realistic and incomparable experience of revolutionary market solutions. We have effectively steered business all over the world through our market research reports with our predictive nature and are exceptionally positioned to lead digital transformations. Thus, we craft greater value for clients by presenting progressive opportunities in the global futuristic market.

This release was published on openPR.